A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Not stated	2026-02-04		NCT03193515

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cedars-Sinai Medical Center	161
Fred Hutchinson Cancer Center	123
Kyoto University	9
National Cancer Institute (NCI)	3015
Nonagen Bioscience Corporation	5
University of California, San Francisco	637
University of Texas	36

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cedars-Sinai Medical Center	Los Angeles	United States	392
Kyoto University Graduate School of Medicine	Kyoto	Japan	1
University of California San Francisco	San Francisco	United States	80
UT Southwestern Medical Center at Dallas	Dallas	United States	5